Immunocore
IMCR
$58.46
Share price
0.79%
Change (1 day)
-1.88%
Change (1 year)
Categories
Immunocore (IMCR) - P/B ratio
P/B ratio as of April 2024 : 6.23
According to Immunocore's latest financial reports the company has a price-to-book ratio of 6.23.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Immunocore - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 7.19 | 8.08% |
| 2022-12-31 | 6.66 | 2.62% |
| 2021-12-31 | 6.49 | |
| 2020-12-31 | N/A | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -61.03% | 🇺🇸 USA |